Rheumatologist
Oregon Health & Science University
Portland, OR, United States
Cong-Qiu Chu, MD, PhD.
Professor of Medicine,
Director, OHSU Early Arthritis Clinic,
Course Director, Immunology for Rheumatology Fellows,
Division of Arthritis and Rheumatic Diseases,
Oregon Health & Science University;
Staff Rheumatologist, VA Portland Health Care System.
Medical School: Jilin University Norman Bethune Medical College, Changchun, Jilin, China.
Postdoctoral Studies: University of London/Kennedy Institute of Rheumatology, London, UK.
Internal Medicine Residency: Peking Union Medical College Hospital and Wayne State University Medical School, Detroit, Michigan
Rheumatology Fellowship: University of Washington Medical School, Seattle, Washington.
Dr. Chu is a physician-scientist who is keenly interested in gaining insights into the pathogenesis and management of rheumatoid arthritis (RA). His contributions include the seminal finding that identified tumor necrosis factor (TNF) as a target for RA therapy. Dr. Chu’s research on the role of T cells in arthritis and other autoimmune diseases helped to identify Th17 rather than Th1 cells as pathogenic T cells in arthritis models of RA. His current research is focused on using small interfering RNA to target IL-17 in Th17 cells for therapy in RA and other autoimmune inflammatory diseases. Dr. Chu now leads the OHSU Early Arthritis Clinic and works on strategies to induce and maintain remission in early RA in clinical studies.
Disclosure information not submitted.
Monday, November 14, 2022
3:45 PM – 3:55 PM Eastern Time
Monday, November 14, 2022
5:00 PM – 6:00 PM Eastern Time
